Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diethylstilbestrol | 16 | 2011 | 49 | 1.310 |
Why?
|
| Prenatal Exposure Delayed Effects | 14 | 2011 | 151 | 0.860 |
Why?
|
| Estrogens, Non-Steroidal | 12 | 2011 | 35 | 0.800 |
Why?
|
| Vaginal Smears | 5 | 2008 | 54 | 0.740 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2008 | 135 | 0.590 |
Why?
|
| Maternal Exposure | 4 | 2009 | 39 | 0.490 |
Why?
|
| Gynecology | 3 | 2007 | 50 | 0.380 |
Why?
|
| Papillomaviridae | 3 | 2006 | 58 | 0.360 |
Why?
|
| Papillomavirus Infections | 3 | 2007 | 120 | 0.330 |
Why?
|
| Obstetrics | 2 | 2007 | 80 | 0.300 |
Why?
|
| Maternal Welfare | 1 | 2008 | 15 | 0.290 |
Why?
|
| Menopause | 2 | 2008 | 249 | 0.290 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2008 | 57 | 0.280 |
Why?
|
| Women's Health Services | 1 | 2007 | 30 | 0.280 |
Why?
|
| Cervix Uteri | 2 | 2006 | 56 | 0.260 |
Why?
|
| Environmental Exposure | 1 | 2008 | 208 | 0.250 |
Why?
|
| Attitude to Health | 1 | 2008 | 279 | 0.250 |
Why?
|
| Smoking | 2 | 2008 | 826 | 0.250 |
Why?
|
| Viral Vaccines | 1 | 2006 | 47 | 0.250 |
Why?
|
| Health Care Costs | 1 | 2007 | 202 | 0.240 |
Why?
|
| Ovarian Neoplasms | 2 | 2005 | 130 | 0.240 |
Why?
|
| Breast Neoplasms | 7 | 2011 | 1118 | 0.240 |
Why?
|
| Vulvar Diseases | 1 | 2004 | 5 | 0.240 |
Why?
|
| Women's Health | 1 | 2007 | 360 | 0.230 |
Why?
|
| Vaccination | 1 | 2006 | 335 | 0.210 |
Why?
|
| Pregnancy | 17 | 2011 | 2213 | 0.210 |
Why?
|
| Uterine Cervical Diseases | 1 | 2002 | 4 | 0.210 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2002 | 77 | 0.190 |
Why?
|
| Physician's Role | 1 | 2002 | 120 | 0.190 |
Why?
|
| Female | 28 | 2011 | 30726 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 4 | 2007 | 705 | 0.170 |
Why?
|
| Adult | 18 | 2010 | 15681 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2003 | 692 | 0.140 |
Why?
|
| Colposcopy | 3 | 2006 | 20 | 0.130 |
Why?
|
| Humans | 28 | 2011 | 59389 | 0.130 |
Why?
|
| United States | 10 | 2009 | 7426 | 0.110 |
Why?
|
| Follow-Up Studies | 9 | 2011 | 2338 | 0.110 |
Why?
|
| Middle Aged | 14 | 2010 | 16314 | 0.100 |
Why?
|
| Genital Neoplasms, Female | 1 | 2011 | 17 | 0.090 |
Why?
|
| Risk | 4 | 2009 | 364 | 0.090 |
Why?
|
| Mass Screening | 2 | 2009 | 648 | 0.090 |
Why?
|
| Surveys and Questionnaires | 9 | 2010 | 2516 | 0.090 |
Why?
|
| Adolescent | 5 | 2008 | 5838 | 0.090 |
Why?
|
| Urogenital Abnormalities | 1 | 2009 | 10 | 0.080 |
Why?
|
| Cohort Studies | 7 | 2010 | 2375 | 0.080 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2007 | 28 | 0.080 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2011 | 28 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 220 | 0.080 |
Why?
|
| Vaginal Neoplasms | 1 | 2008 | 3 | 0.070 |
Why?
|
| Behavior | 1 | 2008 | 36 | 0.070 |
Why?
|
| Papanicolaou Test | 1 | 2008 | 42 | 0.070 |
Why?
|
| Sex Ratio | 1 | 2007 | 8 | 0.070 |
Why?
|
| Physical Examination | 1 | 2008 | 104 | 0.070 |
Why?
|
| Insurance, Liability | 1 | 2007 | 1 | 0.070 |
Why?
|
| Liability, Legal | 1 | 2007 | 18 | 0.070 |
Why?
|
| DNA, Viral | 2 | 2005 | 223 | 0.070 |
Why?
|
| Growth Substances | 1 | 2007 | 34 | 0.070 |
Why?
|
| Immunization Programs | 1 | 2007 | 12 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 364 | 0.070 |
Why?
|
| Risk-Taking | 1 | 2008 | 158 | 0.070 |
Why?
|
| Preventive Medicine | 1 | 2007 | 24 | 0.070 |
Why?
|
| Fetal Blood | 1 | 2007 | 70 | 0.070 |
Why?
|
| Age Factors | 2 | 2008 | 1504 | 0.070 |
Why?
|
| Hormones | 1 | 2007 | 60 | 0.070 |
Why?
|
| Estradiol Congeners | 1 | 2006 | 2 | 0.070 |
Why?
|
| Carcinogens | 1 | 2006 | 37 | 0.070 |
Why?
|
| Menstruation Disturbances | 1 | 2006 | 18 | 0.070 |
Why?
|
| Endocrine Disruptors | 1 | 2007 | 73 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 70 | 0.060 |
Why?
|
| Immunization Schedule | 1 | 2006 | 17 | 0.060 |
Why?
|
| Career Choice | 1 | 2007 | 120 | 0.060 |
Why?
|
| Papillomavirus Vaccines | 1 | 2007 | 67 | 0.060 |
Why?
|
| Hypospadias | 1 | 2005 | 2 | 0.060 |
Why?
|
| Infertility, Male | 1 | 2005 | 57 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2007 | 276 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 323 | 0.060 |
Why?
|
| Ultrasonic Therapy | 1 | 2004 | 8 | 0.060 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2004 | 12 | 0.060 |
Why?
|
| Neuromuscular Agents | 1 | 2004 | 16 | 0.060 |
Why?
|
| Lichen Sclerosus et Atrophicus | 1 | 2004 | 11 | 0.060 |
Why?
|
| Uterine Neoplasms | 1 | 2005 | 29 | 0.060 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2004 | 16 | 0.060 |
Why?
|
| Program Development | 1 | 2006 | 203 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2006 | 188 | 0.060 |
Why?
|
| Pregnancy Outcome | 1 | 2005 | 181 | 0.060 |
Why?
|
| DNA Probes, HPV | 1 | 2004 | 3 | 0.060 |
Why?
|
| Nuclear Family | 3 | 2009 | 17 | 0.050 |
Why?
|
| Physician-Patient Relations | 2 | 2008 | 399 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2006 | 470 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2006 | 256 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2003 | 133 | 0.050 |
Why?
|
| Cell Biology | 1 | 2002 | 21 | 0.050 |
Why?
|
| Progestins | 1 | 2002 | 29 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2009 | 674 | 0.050 |
Why?
|
| Patient Care | 1 | 2002 | 78 | 0.050 |
Why?
|
| Estrogens | 1 | 2002 | 109 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 2003 | 189 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2003 | 197 | 0.050 |
Why?
|
| Postmenopause | 1 | 2002 | 224 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2008 | 1925 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2009 | 746 | 0.040 |
Why?
|
| Risk Factors | 5 | 2010 | 4986 | 0.040 |
Why?
|
| Male | 8 | 2009 | 27749 | 0.040 |
Why?
|
| Neoplasms | 1 | 2008 | 1231 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2007 | 1284 | 0.030 |
Why?
|
| Aged | 2 | 2005 | 13408 | 0.030 |
Why?
|
| Incidence | 2 | 2006 | 1238 | 0.020 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2011 | 8 | 0.020 |
Why?
|
| Stillbirth | 1 | 2011 | 17 | 0.020 |
Why?
|
| Menopause, Premature | 1 | 2011 | 25 | 0.020 |
Why?
|
| Young Adult | 2 | 2010 | 4272 | 0.020 |
Why?
|
| Cryptorchidism | 1 | 2009 | 8 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2009 | 14 | 0.020 |
Why?
|
| Gestational Age | 1 | 2009 | 178 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2006 | 3067 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2008 | 11 | 0.020 |
Why?
|
| Urogenital Neoplasms | 1 | 2008 | 4 | 0.020 |
Why?
|
| Leukemia | 1 | 2008 | 57 | 0.020 |
Why?
|
| Medical Records | 1 | 2008 | 133 | 0.020 |
Why?
|
| American Cancer Society | 1 | 2007 | 3 | 0.020 |
Why?
|
| Child | 2 | 2008 | 4189 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2007 | 20 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2009 | 292 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 322 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 84 | 0.020 |
Why?
|
| Infertility, Female | 1 | 2006 | 44 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2008 | 349 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2007 | 343 | 0.020 |
Why?
|
| Cell Division | 1 | 2007 | 443 | 0.020 |
Why?
|
| Age Distribution | 1 | 2005 | 249 | 0.020 |
Why?
|
| Ovarian Cysts | 1 | 2005 | 4 | 0.010 |
Why?
|
| Leiomyoma | 1 | 2005 | 15 | 0.010 |
Why?
|
| Cytodiagnosis | 1 | 2004 | 44 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2005 | 484 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 132 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2006 | 357 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2008 | 1793 | 0.010 |
Why?
|
| Reproductive History | 1 | 2002 | 15 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 1189 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 651 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1559 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 1091 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 1234 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2008 | 6071 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 19650 | 0.010 |
Why?
|